GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Leadman Biochemistry Co Ltd (SZSE:300289) » Definitions » Debt-to-Equity

Beijing Leadman Biochemistry Co (SZSE:300289) Debt-to-Equity : 0.01 (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Beijing Leadman Biochemistry Co Debt-to-Equity?

Beijing Leadman Biochemistry Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥4.4 Mil. Beijing Leadman Biochemistry Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥3.5 Mil. Beijing Leadman Biochemistry Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥1,739.9 Mil. Beijing Leadman Biochemistry Co's debt to equity for the quarter that ended in Mar. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Beijing Leadman Biochemistry Co's Debt-to-Equity or its related term are showing as below:

SZSE:300289' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01   Med: 0.07   Max: 0.26
Current: 0.01

During the past 13 years, the highest Debt-to-Equity Ratio of Beijing Leadman Biochemistry Co was 0.26. The lowest was 0.01. And the median was 0.07.

SZSE:300289's Debt-to-Equity is ranked better than
99.86% of 703 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs SZSE:300289: 0.01

Beijing Leadman Biochemistry Co Debt-to-Equity Historical Data

The historical data trend for Beijing Leadman Biochemistry Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Leadman Biochemistry Co Debt-to-Equity Chart

Beijing Leadman Biochemistry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.06 0.04 0.03 0.01

Beijing Leadman Biochemistry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

Competitive Comparison of Beijing Leadman Biochemistry Co's Debt-to-Equity

For the Medical Devices subindustry, Beijing Leadman Biochemistry Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Leadman Biochemistry Co's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Beijing Leadman Biochemistry Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Beijing Leadman Biochemistry Co's Debt-to-Equity falls into.



Beijing Leadman Biochemistry Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Beijing Leadman Biochemistry Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Beijing Leadman Biochemistry Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Leadman Biochemistry Co  (SZSE:300289) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Beijing Leadman Biochemistry Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Beijing Leadman Biochemistry Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Leadman Biochemistry Co (SZSE:300289) Business Description

Traded in Other Exchanges
N/A
Address
No.5 Hongda South Road, Beijing, CHN
Beijing Leadman Biochemistry Co Ltd is a biotechnology company based in China. The company is focusing on research and development, manufacture, and sales of in vitro diagnostic (IVD) products. The company has core competencies in biochemistry, in vitro diagnostic reagents and instruments. Its product offering includes biochemical raw materials such as enzymes, coenzymes, antibodies, buffers, and enzyme substrates; biochemistry diagnostic and companion reagents; and medical test instruments.
Executives
Ding Yao Liang Executives
Wang Xiao Hong Supervisors
Zhang Hai Tao Executives
Zhang Ya Li Supervisors
Sun Qian Director
Wang Jian Hua Directors, executives
Wang Yi Xing Directors, executives
Yang Lu Ping Securities Affairs Representative
Niu Ju Hui Secretary Dong
Zhang Kun Director
Shen Guang Qian Directors, executives
Ma Yan Wen Director
Wang Lan Zhen Directors, executives

Beijing Leadman Biochemistry Co (SZSE:300289) Headlines

No Headlines